- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Novartis teams up with Becoming rentABLE for its new SMA campaign | ||
| Do | Ionis scores transformational FDA label expansion for Tryngolza | ||
| Do | Jubilant HollisterStier gets FDA warning letter for quality control problems | ||
| Do | AstraZeneca spells out a community cancer screening strategy with the YMCA | ||
| 24.06. | Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief | ||
| 24.06. | Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance | ||
| 24.06. | Stada, under new CapVest ownership, picks up horde of European consumer brands | ||
| 24.06. | Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report | ||
| 24.06. | Amid safety concerns, ADC Therapeutics plots 17% staff cuts to push resources behind Zynlonta | ||
| 24.06. | Revance taps dancer Julianne Hough to choreograph social media push for Botox rival | ||
| 23.06. | Incyte drops lawsuit as CMS relents on classification of Opzelura | ||
| 23.06. | Novartis' 'Relax Your Tight End' prostate cancer campaign wins Cannes Lions Pharma Grand Prix | ||
| 22.06. | CARsgen makes history as China approves world's first CAR-T therapy for solid tumors | ||
| 22.06. | US to investigate Germany's proposed drug spending reforms | ||
| 22.06. | Alnylam scolded over promotional activity after Pfizer complaint | ||
| 18.06. | FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition | ||
| 18.06. | Why a deviation investigation still takes two weeks in the age of AI | ||
| 18.06. | Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma | ||
| 18.06. | Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix | ||
| 18.06. | Amid industry's cell therapy automation push, Cellares and Ori dominate the field: report | ||
| 17.06. | 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line | ||
| 17.06. | Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer | ||
| 17.06. | GSK runs first DTC ad for would-be asthma blockbuster Exdensur | ||
| 17.06. | Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports | ||
| 17.06. | Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.